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We used the nation-wide Swedish Family-Cancer Database to examine the risk for testicular cancer in offspring through parental and
sibling probands. Among 0–68-year-old offspring, 4082 patients had testicular cancer in years 1961–2000, among whom 68 (1.67%)
had an affected father/brother. Standardized incidence ratios (SIRs) for familial risk were four-fold when a father and nine-fold when a
brother had testicular cancer. Histology-specific risks (for the testicular cancer) were similar for sons of affected fathers, but were
higher among brothers for teratoma and seminoma than for mixed histologies. Standardized incidence ratios for either histology
depended on the age difference between the brothers: 10.81 when the age difference was less than 5 years compared to 6.69 for a
larger age difference. Parental colorectal, pancreatic, lung and breast cancer and non-Hodgkin’s lymphoma and Hodgkin’s disease
were associated with seminoma among sons. Seminoma risk was also increased when a sibling had melanoma. Teratoma was
associated with parental lung cancer and melanoma. The high familial risk may be the product of shared childhood environment and
heritable causes. Familial cases of fraternal pairs with an early-onset teratoma represent a challenge for gene identification.
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The incidence of testicular cancer has increased in many countries,
including Sweden, two- to four-fold over the last half a century, for
unknown reasons (Bergstrom et al, 1996; Centre for Epidemiology,
2002). Of the two main types, seminomas and nonseminomas, the
latter include teratomas with somatic differentiation and undiffer-
entiated embryonal tumours (Kumar et al, 1997). However, some
60% of germ cell tumours of the testis contain multiple histological
types and only 40% contain a single histological type (Kumar et al,
1997). The aetiology of testicular cancer remains largely unknown;
some identified or suggested risk factors include undescended
testis (cryptorchidism), a prior history of cancer in one testis (the
opposite testis is at increased risk), in utero hormonal exposures,
perinatal factors and family history of testicular cancer (Forman
et al, 1992, 1994; Heimdal et al, 1997; Moller and Skakkebaek,
1997; Swerdlow et al, 1997; Westergaard et al, 1998; Jacobsen et al,
2000; Hemminki and Mutanen, 2001). Compared to the relatively
high incidence of testicular cancer in Sweden, first-generation
immigrants generally show a decreased risk of testicular cancer
compared to the natives, but this difference disappears in the next
generation; this effect is marked among the sons of Finnish
immigrants, whose risk is doubled compared to their fathers
(Hemminki and Li, 2002b; Hemminki et al, 2002). Among the sons
of the Danish immigrants, an equally large but opposite change
takes place (Hemminki and Li, 2002a).
In the present study, we have examined the genetic epidemiol-
ogy of histology-specific testicular cancer in order to distinguish
the contribution of heritable and environmental effects to etiology.
Compared to the previous testicular cancer study from the Swedish
Family-Cancer Database, an extended population and hence some
50% more familial testicular cancer cases are available (Dong et al,
2001), allowing analysis by age of onset through parental and
fraternal probands. This, the largest cohort study of familial
testicular cancer, offers new insight into the aetiology of the
disease.
SUBJECTS AND METHODS
Statistics Sweden maintains a ‘Multigeneration Register’ in which
offspring, born in Sweden in 1932 and later, are registered with
their parents (as declared at birth) and they are organized as
families (Hemminki et al, 2001a). Information on the Database is
available at the Nature Genetics website as ‘Supplementary
information’ (Hemminki and Granstrom, 2002). The data on
families and cancers have a complete coverage, barring some
groups of deceased offspring born in the 1930s and who died
before 1991. Although this small group of offspring with missing
links to parents has a negligible effect on the estimates of familial
risk (Hemminki and Li, 2003), we limited the present study to
offspring whose parents were known, to eliminate this possible
source of bias. The ‘Multigeneration Register’ was linked using the
individually unique national registration number to the Cancer
Registry for the years 1958–2000. Cancer registration is considered
now to be close to 100% complete (Centre for Epidemiology, 2002).
Received 24 October 2003; revised 9 January 2004; accepted 19 January
2004; published online 16 March 2004
*Correspondence: Dr X Li, Department of Biosciences at Novum,
Karolinska Institute, 141 57 Huddinge, Sweden; E-mail: xinjun.li@cnt.ki.se
British Journal of Cancer (2004) 90, 1765–1770
& 2004 Cancer Research UK All rights reserved 0007– 0920/04 $25.00
www.bjcancer.com
E
p
i
d
e
m
i
o
l
o
g
yThe registered site of cancer is as a four-digit diagnostic code
based on the 7th revision of the International Classification of
Diseases (ICD-7). The following ICD-7 codes were grouped: ‘upper
aerodigestive tract’ cancer codes 161 (larynx) and 140–148 (lip,
mouth, pharynx), except for code 142 (salivary glands), ‘lympho-
ma’ codes 200, 202 (non-Hodgkin lymphoma), 201 (Hodgkin’s
disease) and ‘leukemia’ codes 204–207 (leukemias), 208 (poly-
cytemia vera) and 209 (myelofibrosis). Rectal cancer, ICD-7 code
154, was subdivided into the anus (squamous cell carcinoma,
154.1) and mucosal rectum (154.0). Basal cell carcinoma of the
skin is not registered in the Cancer Registry. Up to 1992, the
histology of testicular cancers as in the Cancer Registry (WHO/HS/
CANC/24.1 Histology Code) was used, to define seminoma
(pathology codes 066) and teratoma (826, also including embry-
onal tumours). From 1993, ICD-O-2/ICD with histopathological
data according to the Systematized Nomenclature of Medicine
(SNOMED, http://snomed.org) was used, referred to here as
‘SNOMED’.
Standardized incidence ratios (SIRs) were used to measure
cancer risks for sons (i.e., offspring) according to the occurrence of
cancers in their families. When more than two affected sons were
found in any family, they were counted as independent events.
Standardized incidence ratios were calculated for sons whose
parents or brothers had the same, concordant cancer, that is, using
parents or brothers as probands. Follow-up started for each
offspring at birth, immigration or January 1, 1961, whichever came
latest, and terminated on diagnosis of the first cancer, death,
emigration, or the closing date of the study, December 31, 2000.
Parents’ ages were not limited but sons were 0–68 years of age.
All tumour incidence rates were based on the data in the Family-
Cancer Database, and they were essentially similar to rates in the
Swedish Cancer Registry. Rates were standardized to the European
population. Standardized incidence ratios were calculated as the
ratio of observed (O) to expected (E) number of cases. The
expected numbers were calculated from 5-year-age-, sex-, tumour
type-, period- (5-year bands), socioeconomic status- (six groups)
and residential area- (three groups) specific standard incidence
rates for all sons lacking a family history (Esteve et al, 1994).
Confidence intervals (95% CI) were calculated assuming a Poisson
distribution (Esteve et al, 1994). Risks for siblings were calculated
using the cohort method, described elsewhere (Hemminki et al,
2001b).
The kappa statistic was used as the measure of agreement
between histologies: (observed number of cases expected number
of cases)/(1 expected number of cases) (Armitage and Berry,
1994). The kappa can assume values between  1 and 1; 0 shows a
complete chance occurrence and  1 or 1 show a completely
determined occurrence. Values between 0.40 and 0.60 are
considered moderately determined occurrences. A negative kappa
value would, in the present context, indicate a determined
occurrence of a discordant histology, which is biologically
unlikely, so we present only positive values of kappa in this paper.
RESULTS
The Family-Cancer Database, which covered years 1961–2000
from the Swedish Cancer Registry, included 4082 testicular cancers
in sons of ages 0–68 years and 3878 fathers with testicular cancer
(Table 1). Seminoma accounted for 49.8% and teratoma 48.4% in
sons, while in fathers the proportions were 59.1 and 38.2%,
respectively. Seminoma showed a 6–8-year later median age of
onset than teratoma (35 vs 27 in offspring and 39–33 in fathers).
According to the SNOMED histology, covering years 1993–2000,
embryonal carcinoma accounted for 14.8% in sons and 10.9% in
fathers. The age-specific incidence rates of testicular cancer among
sons are shown in Figure 1 according to the SNOMED histology.
The peak incidence for teratoma and embryonal carcinoma
occurred at ages 20–24 years, and for seminoma showed a peak
incidence at 30–34 years.
Table 2 presents risks for the histological types among brothers
according to their age difference. Those born less than 5 years
apart had higher risks, particularly at ages over 24 years, but below
age 25 for the teratoma showed no age difference.
Age- and histology-specific familial risk for testicular cancer was
analysed using fathers or brothers as probands (Table 3). The
overall SIRs were approximately two-fold higher between brothers
(8.58) than between sons and fathers (3.78). The risks were slightly
higher for unmixed histologies compared to the mixed histologies
for all significant SIRs. Among brothers, the SIR for concordant
teratoma was 11.50, compared to 9.75 for seminoma. Concordant
teratoma showed the highest SIR (14.35) among brothers aged 0–
24 years. The proportion of sons with testicular cancer who had an
affected father or brother was 1.67% (68 familial cases from Table 3
to 4082 cases from Table 1). Median ages of the familial cases did
not differ from those of all cases (data not shown).
Age-specific familial SIR for seminoma is shown in Figure 2A
for sons of fathers and among brothers with testicular cancer;
Figure 2B shows the curves for teratoma. The shapes of the curves
for teratoma resemble each other independent of proband status,
with two peaks at 15–24 and 30–39 years. For seminoma, the peak
SIR was observed at ages 40–44 years among brothers, and at 45–
49 years among sons of affected fathers.
We analysed using SNOMED histopathology, available only
from 1993 (data not shown), that teratoma showed an age peak at
15–29 years in sons of fathers with testicular cancer (N¼3,
SIR¼8.48, 95% CI 1.60–25.10). Among brothers, both SNOMED
types showed peak SIRs at 30–44 years (seminoma, N¼10,
Table 1 Numbers of cases of testicular cancer in sons and fathers
Son Father
Histopathological type No. % Mean age Median age No. % Mean age Median age
Pathology (1961–2000)
Seminoma 2032 49.8 35.8 35 2293 59.1 41.1 39
Teratoma 1974 48.4 27.5 27 1483 38.2 33.1 33
Others 76 1.9 29.9 27 102 2.6 46.7 43
All 4082 100.0 31.7 31 3878 100 38.2 36
SNOMED (1993–2000)
Seminoma 871 56.4 37.7 36 673 66.2 42.0 39
Teratoma 385 25.0 28.8 27 193 19.0 35.6 33
Embryonal carcinoma 228 14.8 28.4 27 111 10.9 34.7 32
Others 59 3.8 28.5 28 40 3.9 42.6 37
All 1543 100.0 33.8 33 1017 100.0 40.0 37
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CI 6.26–61.55). No familial cases were found for embryonal
carcinoma.
Table 4 presents associations of testicular cancer with other
cancers in families, including mothers and sisters. Both seminoma
(1.19) and teratoma (1.13) were increased when parents had any
cancer (only associations at discordant sites being considered). For
seminoma, a significantly increased risk was found when parents
had colorectal, pancreatic, lung and breast cancer and non-
Hodgkin’s lymphoma and Hodgkin’s disease. Seminoma was also
increased when a sibling (brother or sister) had melanoma.
Teratoma was associated with parental lung cancer and melanoma.
For testicular cancer as a whole, an increased risk was found when
the mother was diagnosed with ‘other uterine tumours’ or the
father with nervous system cancer; these uterine tumours included
three leiomyosarcomas, two adenocarcinomas, two chorioncarci-
nomas, two embryonal sarcomas, one stroma cell sarcoma and two
unspecified sarcomas. It was also noteworthy that there were three
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Figure 1 Age-specific incidence of testicular cancer in offspring
according to the SNOMED histology in years 1993–2000.
Table 2 SIR for histological type of testicular cancer in brothers by age difference
Brothers ages o5 years Brothers ages X5years
Histological types Age at diagnosis O SIR 95% CI O SIR 95% CI
Seminoma 0–24 1 11.49 0.00 65.89 0
424 14 10.62 5.79 17.87 11 6.81 3.38 12.22
All 15 10.67 5.96 17.65 11 6.40 3.18 11.49
Teratoma 0–24 5 11.61 3.66 27.31 5 10.74 3.39 25.26
424 9 10.18 4.61 19.41 6 5.73 2.06 12.56
All 14 10.65 5.80 17.91 11 7.27 3.61 13.06
All types 0–24 7 13.08 5.18 27.10 5 8.54 2.69 20.08
424 23 10.27 6.50 15.44 17 6.29 3.66 10.09
All 30 10.81 7.29 15.45 22 6.69 4.19 10.15
Bold type: 95% CI does not include 1.00. O¼observed; SIR¼standardised incidence ratio; CI¼confidence interval.
Table 3 SIR for histological types of testicular cancer in the offspring of paternal and fraternal probands
Seminoma Teratoma All types
Histological types in proband Age at diagnosis O SIR 95% CI O SIR 95% CI O SIR 95% CI
Paternal proband
Seminoma 0–24 0 3 4.62 0.87 13.69 3 3.78 0.71 11.18
424 4 3.52 0.92 9.11 3 3.6 0.68 10.66 7 3.50 1.39 7.26
All 4 3.18 0.83 8.23 6 4.05 1.46 8.87 10 3.58 1.71 6.61
Teratoma 0–24 0 3 8.64 1.63 25.58 3 7.2 1.36 21.32
424 2 4.01 0.38 14.76 0 2 2.28 0.22 8.39
All 2 3.61 0.34 13.27 3 4.2 0.79 12.45 5 3.87 1.22 9.1
All types 0–24 0 7 6.85 2.71 14.18 7 5.63 2.23 11.66
424 6 3.53 1.27 7.73 3 2.42 0.46 7.15 9 3.02 1.37 5.75
All 6 3.19 1.15 6.98 10 4.42 2.1 8.15 16 3.78 2.16 6.16
Fraternal proband
Seminoma 0–24 1 11.7 0 67.04 3 7.79 1.47 23.07 5 10.29 3.25 24.22
424 15 9.65 5.38 15.95 6 6.11 2.2 13.38 21 8.15 5.03 12.47
All 16 9.75 5.56 15.88 9 6.58 2.98 12.55 26 8.49 5.54 12.45
Teratoma 0–24 0 7 14.35 5.69 29.74 7 11.53 4.57 23.89
424 9 6.88 3.12 13.12 9 9.95 4.51 18.98 18 8.02 4.74 12.7
All 9 6.39 2.9 12.18 16 11.50 6.55 18.71 25 8.76 5.67 12.96
All types 0–24 1 5.27 0 30.2 10 11.16 5.31 20.6 12 10.71 5.51 18.76
424 25 8.52 5.51 12.59 15 7.77 4.33 12.84 40 8.1 5.78 11.03
All 26 8.32 5.43 12.21 25 8.84 5.72 13.07 52 8.58 6.41 11.26
Bold type: 95% CI does not include 1.00. O¼observed, SIR¼standardised incidence ratio; CI¼confidence interval.
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cancer (SIR¼7.49, 95% CI¼1.41–22.18), of whom two pairs of
brothers had seminoma (SIR¼11.07, 95% CI¼1.04–40.71).
The kappa test was applied to assess the histological con-
cordance of testicular cancer (data not shown). The overall value
was 0.01 between sons and fathers, and 0.26 among brothers;
among brothers, the kappa value of seminoma was 0.23 and that of
teratoma was 0.31.
DISCUSSION
The Swedish Family-Cancer Database contains national family
data linked to the Swedish Cancer Registry. The inability to link
some 10% of deceased offspring diagnosed with cancer to their
parents (see Subjects and Methods) may cause small errors in the
familial risks of fatal cancers. However, testicular cancer has had a
good prognosis during the past decades. The missing links
predominantly influence those born in the 1930s and who died
before 1991, and we have not observed a difference in familial risks
in comparing different diagnostic periods (Hemminki and Li,
2003). We conclude that this gap in parental links has no large
effect on the present estimates. The markedly improved survival in
testicular cancer may also be a source of bias, but adjustment for
period should have minimized this. The many comparisons are
relevant and, undoubtedly, some associations were due to chance;
consistency within this study and with other studies, as well as
biological plausibility, need assessing for causal inference.
Familial occurrence of testicular cancer is well recognized but
rare. The proportion of sons with testicular cancer who had an
affected father or brother was 1.67% in the present study,
consistent with previous studies, reporting affected first-degree
relatives in 1.0–2.8% of cases (Heimdal et al, 1996; Westergaard
et al, 1996; Dieckmann and Pichlmeier, 1997; Hemminki and
Czene, 2002). Even the present overall familial risks of 3.78 (son–
father) and 8.58 (brothers) were in line with the literature
(Westergaard et al, 1996; Dieckmann and Pichlmeier, 1997;
Heimdal et al, 1997; Dong et al, 2001). The SNOMED data,
covering cases diagnosed between 1993 and 2000, showed an even
larger difference between the two proband groups, 3.12 (son–
father) and 9.62 (brothers), respectively. There was no large
difference in familial risks between seminomas and teratomas
among father–son pairs. However, there appeared to be a large
difference in the familial risk between the pure and mixed
histological types among brothers. The risks ranged from 12
(teratoma–teratoma) and 10 (seminoma–seminoma) for pure
histologies to six for mixed histologies. Consistent with these
findings, the kappa test was 0.01 between sons and fathers, whereas
between brothers seminoma showed a value of 0.23 and teratoma a
value of 0.31. These are still low values, but the interpretation is
difficult because of the relatively small number of cases. The lower
kappa values between sons and fathers than between brothers may
be due to a more defined disease phenotype within one generation
than between two generations.
The higher familial risk for testicular cancer among brothers
than father–son pairs may suggest the involvement of a recessive
mode of inheritance or an X-linked susceptibility locus in the
aetiology of testicular cancer, consistent with the segregation
analysis and the gene-mapping findings (Heimdal et al, 1997;
Rapley et al, 2000). Such results would point to the importance of
the maternal lineage of inheritance and perhaps also maternally
exerted environmental factors. The difference in SIR among
brothers close in age (10.81) compared to those further apart
(6.69) suggests environmental effects. Testicular cancer has been
reported as the site with the highest proportion of childhood-
shared environmental effects in a family study of all major cancers
(Czene et al, 2002). Although both histological types showed the
effect of age difference, the risks for early-onset teratoma appeared
to be least influenced by the age difference. These results suggest
that environmental factors during childhood and adolescence
influence the risk of contracting a late-onset testicular cancer
(Hemminki et al, 2002; Hemminki and Li, 2002b). Identifying these
factors might explain the riddle of increasing incidence trends and
also the difference between immigrants and their sons (Hemminki
and Li, 2002a). On the other hand, the search for heritable effects
should target brother pairs with an early-onset teratoma.
Age-specific familial risks of Figure 2 showed the highest risks
for seminoma in the 40s, for both brothers and son–father pairs.
For teratoma, two discrete peaks were noted, particularly among
brothers. The early-onset teratoma peak (20–24 years) coincided
with its peak incidence, but the late-onset peak (35–39 years)
occurred 15 years later and close to the peak fraternal risk of
seminoma. Based on the risks by age difference, the younger
teratoma component may be the most heritable familial compo-
nent, whereas the later component of teratoma and seminoma may
have a strong environmental origin.
In families of seminoma patients, associations were found with
colorectal, pancreatic, lung and breast cancer and non-Hodgkin’s
lymphoma and Hodgkin’s disease among parents. Among
brothers, there was an association with seminoma and melanoma.
Teratoma was associated with parental lung cancer and melanoma.
However, no association has been found for primary melanoma or
lung cancer following first testicular cancer (Dong et al, 2001).
Testicular cancer was associated with mothers’ unusual uterine
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4.20). No oestrogen-related cancer risks were observed in mothers
of testicular cancer patients in a Danish study (Kroman et al,
1996). In the 26 families in our study with two sons with testicular
cancer, three had mothers with colorectal cancer (SIR¼7.49, 95%
CI¼1.41–22.18), of whom two pairs of brothers had seminoma
(SIR¼11.07, 95% CI¼1.04–40.71), but none had a father with
testicular cancer. However, there is no previous evidence of an
association between testicular and colorectal cancers, but multiple
testing may have resulted in associations due to chance.
In summary, the present study may offer some explanation to
the inability in finding susceptibility genes for testicular cancer.
The high familial risk may be the product of shared childhood
environment and heritable causes and so may be difficult to
untangle. Identifying any relevant environmental factors will be
challenging but may explain some of the changes in testicular
cancer incidence. For gene identification, fraternal pairs with
teratoma below age 25 may be particularly useful.
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Myeloma 12 1.04 0.54 1.83 8 0.93 0.40 1.85
Leukaemia 25 1.18 0.76 1.74 19 1.16 0.69 1.81 3 0.78 0.15 2.31 1 0.30 0.00 1.73
All 874 1.19 1.11 1.27 653 1.13 1.04 1.22 131 1.19 0.99 1.41 87 1.13 0.91 1.40
Bold type: 95% CI does not include 1.00. O¼observed; SIR¼standardised incidence ratio; CI¼confidence interval.
aThree colorectal cancer-affected mothers had each two
sons with testicular cancer, giving an SIR¼7.49, 95% CI¼1.41–22.18; of whom two pairs of bothers had seminoma, giving SIR¼11.07 and 95% CI¼1.04–40.71.
bFor all types
of testicular cancer by mother’s uterine cancer, SIR¼2.40, 95% CI¼1.23–4.20.
cFor all types of testicular cancer by father’s nervous system cancer, SIR¼1.50, 95% CI¼1.03–
2.10.
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